Van Hauwermeiren Timothy

Denali Therapeutics Inc. · Director

Van Hauwermeiren Timothy is listed in public filings as director. This Van Hauwermeiren Timothy insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Denali Therapeutics Inc. (DNLI), Lexeo Therapeutics, Inc. Common Stock (LXEO), and iTeos Therapeutics, Inc. (ITOS). Investors use Van Hauwermeiren Timothy's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Denali Therapeutics Inc.DNLI$378k19.2k sharesGrant / ExerciseJun 3, 2026$378.0K19.2k shares$19.66--
Denali Therapeutics Inc.DNLI--17k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable6.4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Denali Therapeutics Inc.DNLI$476k31.9k sharesGrant / ExerciseNov 4, 2025$475.9K31.9k shares$14.92--
Denali Therapeutics Inc.DNLI--10.6k sharesGrant / ExerciseNov 4, 2025Disclosure amount unavailable10.6k shares----
Lexeo Therapeutics, Inc. Common StockLXEO$96k22.9k sharesGrant / ExerciseJun 26, 2025$95.8K22.9k shares$4.18--
iTeos Therapeutics, Inc.ITOS$022.3k sharesGrant / ExerciseMay 13, 2025$96.1K22.3k shares$4.30--
iTeos Therapeutics, Inc.ITOS$395k24.2k sharesGrant / ExerciseJun 11, 2024$394.9K24.2k shares$16.32--